Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA
von Schoultz, B.
Lakartidningen 99(34): 3276-3278
2002
ISSN/ISBN: 0023-7205 PMID: 12362844 Document Number: 543505
Document emailed within 1 workday
Related Documents
Kovacs, G.T.; Chick, P. 1990: Hormone replacement therapy at the menopause. the risks and benefits Australian Family Physician 19(1): 731995: Report: the pill's health benefits appear to far outweigh its risks Journal of the Oklahoma State Medical Association 88(1): 38
Wahl, D.G.; Bounameaux, H.; de Moerloose, P.; Sarasin, F.P. 2000: Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis Archives of Internal Medicine 160(13): 2042-2048
Jamin, C. 1999: After how long should hormone replacement therapy be interrupted? Contraception Fertilite Sexualite 27(3): 187-190
Huland, H. 1996: The risks outweigh the benefits of radical prostatectomy in localised prostate cancer: the argument against European Urology 29(Suppl): 31-33
Ohta, H. 2007: Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women Clinical Calcium 17(9): 1315-1324
Herndon, D.N.; Rose, J.K. 1996: Cadaver skin allograft and the transmission of human cytomegalovirus in burn patients: benefits clearly outweigh risks Journal of the American College of Surgeons 182(3): 263-264
Griffiths, F. 1995: Women's health concerns. Is the promotion of hormone replacement therapy for prevention important to women? Family Practice 12(1): 54-59
Kessler, C.M.; Legault, C. 1995: Effect of hormone replacement therapy on the activities of factor VII and protein C in postmenopausal women women The postmenopausal estrogen/progestin intervention trial Blood 86(10 Suppl 1): 200A
Brynhildsen, J. 2013: Birth control pills and thrombosis--again. Benefits outweigh the risks--low risk with long-acting contraceptive methods Lakartidningen 110(49-50): 2227
Brynhildsen, J. 2013: Birth control pills and thrombosis--again. Benefits outweigh the risks--low risk with long-acting contraceptive methods Lakartidningen 110(49-50): 2227
Sharts-Hopko, N.C. 1995: Hormone replacement therapy and cardiovascular health in midlife women Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 4(4): 314-316
Chaikittisilpa, S.; Jirapinyo, M.; Chaovisitsaree, S.; Wipatavit, V.; Bunyaviroch, S.; Kanluan, B.; Panyakhamlerd, K.; Jaisamrarn, U.; Taechakraichana, N. 2007: Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics Journal of the Medical Association of Thailand 90(4): 628-635
Magnusson, C.; Persson, I. 1997: Hormone therapy in climacteric. Varying research results on risks and benefits Lakartidningen 94(13): 1176-1179
Warren, M.P. 2010: Hormone therapy for menopausal symptoms: putting benefits and risks into perspective Journal of Family Practice 59(12): E1-E7
Hlatky, M.A.; Boothroyd, D.; Vittinghoff, E.; Sharp, P.; Whooley, M.A. 2002: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial JAMA 287(5): 591-597
Civitelli, R.; Pilgram, T.K.; Dotson, M.; Muckerman, J.; Lewandowski, N.; Armamento-Villareal, R.; Yokoyama-Crothers, N.; Kardaris, E.Eugenia.; Hauser, J.; Cohen, S.; Hildebolt, C.F. 2002: Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial Archives of Internal Medicine 162(12): 1409-1415
Burnand, B.; Cornuz, J.; Wirthner, D.; Lamy, O. 2003: Hormone replacement therapy: thoroughness in method and interpretation of results. Regarding the Women's Health Initiative--WHi Revue Medicale de la Suisse Romande 123(5): 277-281
Panico, S.; Galasso, R.; Celentano, E.; Ambrosca, C.; Asti, A.; Frova, L.; Capocaccia, R.; Berrino, F. 1997: Hormone replacement therapy and cardiovascular diseases: different populations, different risks Annali Dell'istituto Superiore di Sanita 33(2): 203-206
Wise, J. 2014: Cons outweigh pros of preventive aspirin in women, study finds Bmj 349: G7466